Cannabis Canadabis Capital Unveils New 60%+ Double-Infused Pre-Roll under Dab Bods Brand, Setting New Standard for THC Potency in Canadian Market April 24, 2024
Cannabis RIV Capital Sets Date for Financial Results for the Fiscal Quarter and Nine-Month Transition Year Ended December 31, 2023 April 23, 2024
Cannabis Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain April 23, 2024
Cannabis Canopy Growth Announces CBI Conversion to Exchangeable Shares and Newly Constituted Board of Directors April 19, 2024